Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting (CROSBI ID 710594)
Prilog sa skupa u časopisu | prošireni sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Omrčen Tomislav, Eterović Davor, Vrdoljak Eduard
engleski
Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting
Predictors of resistance of abiraterone and enzalutamide in metastatic castration resistant prostate cancer.
abiraterone, enzalutamide, prostate cancer, resistance
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
3491-3492.
2019.
nije evidentirano
objavljeno
10.1016/ S1569-9056(19)34647-0
Podaci o matičnoj publikaciji
European urology supplements
Elsevier
1569-9056
1878-1500
Podaci o skupu
11. European Multidisciplinary Congress on Urological Cancers
poster
14.11.2019-17.11.2019
Beč, Austrija
Povezanost rada
Kliničke medicinske znanosti